Tus kws kho mob
QP58-20 Commercial Pharmacy Benefit Exclusion for Medical Drugs Anjeso™ , Fetroja™ and Potassium Phosphates
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2511 - 2520 ntawm 4139
Tus kws kho mob
QP59-20 MHCP Pharmacy Benefit Exclusion for DurystaTM and Fensolvi®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
QP60-20 Commercial Pharmacy Benefit Exclusion for Procysbi® Delayed-Release Granules
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
P46-20 Genetic/Molecular Lab Test Coding Reimbursement Policy
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P52-20 Emergency Department Level of Service Coding Reimbursement Policy
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P53-20 New Reimbursement Policy: Inpatient Non-Reimbursable Unbundling
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P51-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P47-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 31, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P50-20 eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment (DME), Home Health Care (HHC), and Post-Acute Care (PAC) Services for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P49-20 CERiS Review of High Dollar Claims
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020